The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Solution
Multiplex PCR Testing Built for the Point of Care
An evolving world deserves evolved diagnostics. As the leader in syndromic PCR testing, bioMérieux has evolved our point-of-care respiratory testing solution by developing new products that put clinicians and patients front and center. bioMérieux is pleased to announce a revolutionary portfolio of versatile respiratory PCR tests that give clinicians options as they care for a variety of patients.
- Product Overview
- Technical Details
- Service & Support
- Resources
Product Overview
The BIOFIRE® SPOTFIRE® System
The SPOTFIRE System is the latest advancement in molecular infectious disease diagnostics. It is designed to run the SPOTFIRE Respiratory/Sore Throat Panels.
- Requires minimal benchtop space and can be scaled vertically, up to four modules, enabling customizable throughput
- Easy to use with an intuitive system interface and streamlined workflow
- Can be used by any healthcare professional in any healthcare setting
- Seamlessly connects with point-of-care data management systems and other compatible systems and software
1. Calculation based on running the BIOFIRE® SPOTFIRE® R PANEL (~15 minutes) in an 8 hour shift.
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
1 PCR Test. Up to 15 Targets. ~15 Minutes.
The SPOTFIRE R/ST Panel enables testing for both respiratory or sore throat pathogens on the same panel, providing a flexible respiratory solution to meet the unique needs of your care setting. FDA CLEARED | CLIA WAIVED
| Sample Type: | Nasopharyngeal or throat swab in transport media |
| Hands-on time: | 1-2 minutes |
| Overall Respiratory Performance (NPS specimens): | PPA: 98.5% NPA: 99.1% |
| Overall Sore Throat Performance (TS specimens): | PPA: 95.9% NPA: 99.0% |
| RESPIRATORY | SORE THROAT | |
|---|---|---|
| VIRUSES: | VIRUSES: | |
|
| |
| BACTERIA: | BACTERIA: | |
|
|
BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
1 PCR Test. 5 Targets. ~15 Minutes.
The SPOTFIRE R/ST Panel Mini tests for the 5 most probable viruses or bacteria that cause respiratory and sore throat symptoms, including influenza, rhinovirus, respiratory syncytial virus, SARS-CoV-2, and Streptococcus pyogenes.
FDA CLEARED | CLIA WAIVED
Panel Specifications
| Sample Type: | Nasopharyngeal or throat swab in transport media |
| Hands-on time: | 1-2 minutes |
| Overall Respiratory Performance (NPS specimens): | PPA: 98.7% | NPA: 98.4% |
| Overall Sore Throat Performance (TS specimens): | PPA: 96.2% | NPA: 97.9% |
| RESPIRATORY | SORE THROAT |
|---|---|
| VIRUSES: | VIRUSES: |
|
|
| BACTERIA: | |
|
Rethink the Power of Diagnostics with the SPOTFIRE Respiratory/Sore Throat Solution to Potentially:
Inform Clinical Decisions
- High sensitivity, specificity, and reliability provides results clinicians can trust
- Contrary to tests that only detect the flu, SARS-COV-2, and/or RSV, a syndromic panel provides a fuller picture that may help inform patient management decisions
Optimize Operations
- The simplified workflow and quick turnaround time enable rapid and accurate answers during the patient visit, while reducing the need for callbacks or expensive and slow send-out testing
- This easy-to-use solution enables users of all skill levels to prepare and run samples
Optimize Antimicrobial Stewardship
- Receiving comprehensive results in a clinically actionable timeframe may inform diagnoses while optimizing care and antimicrobial stewardship
Improve Patient Satisfaction
- Using the right test, the first time to detect multiple pathogens may result in reduced follow-up appointments, swabbing, and testing, which could improve patient comfort, experience, and convenience
Product availability varies by country. Consult your bioMérieux representative.
Reference:
- Calculation based on running the BIOFIRE® SPOTFIRE® R PANEL (~15 minutes) in an 8 hour shift.
- Overall performance and SARS-CoV-2 performance based on the prospective clinical study for the BIOFIRE SPOTFIRE Respiratory Panel.